GCP
GSA Capital Partners Portfolio holdings
AUM
$1.43B
1-Year Return
20.34%
This Quarter Return
+12.71%
1 Year Return
+20.34%
3 Year Return
+63.52%
5 Year Return
+120%
10 Year Return
+237.47%
AUM
$1.43B
AUM Growth
+$322M
(+29%)
Cap. Flow
+$246M
Cap. Flow
% of AUM
17.2%
Top 10 Holdings %
Top 10 Hldgs %
6.36%
Holding
2,241
New
645
Increased
572
Reduced
474
Closed
546
Top Buys
| 1 |
NVIDIA
NVDA
|
+$16M |
| 2 |
Apple
AAPL
|
+$13.6M |
| 3 |
Microsoft
MSFT
|
+$13M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$8.08M |
| 5 |
JPMorgan Chase
JPM
|
+$7.42M |
Top Sells
| 1 |
CSX Corp
CSX
|
+$4.47M |
| 2 |
Blackstone
BX
|
+$4.34M |
| 3 |
WK Kellogg Co
KLG
|
+$3.21M |
| 4 |
Cal-Maine
CALM
|
+$2.92M |
| 5 |
nVent Electric
NVT
|
+$2.69M |
Sector Composition
| 1 | Technology | 18.52% |
| 2 | Financials | 15.35% |
| 3 | Healthcare | 14.19% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 11.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Aehr Test Systems
AEHR
$797M
| $1.54M | 0.11% |
+118,700
| New | +$1.54M |
|
227
Abbott
ABT
$224B
| $1.52M | 0.11% |
11,192
+9,197
| +461% | +$1.25M |
|
228
Allison Transmission
ALSN
$7.4B
| $1.52M | 0.11% |
16,021
+8,176
| +104% | +$777K |
|
229
Onto Innovation
ONTO
$5.15B
| $1.52M | 0.11% |
15,076
+8,332
| +124% | +$841K |
|
230
Theravance Biopharma
TBPH
$687M
| $1.52M | 0.11% |
137,951
-44,399
| -24% | -$490K |
|
231
Kodiak Gas Services
KGS
$2.93B
| $1.52M | 0.11% |
+44,280
| New | +$1.52M |
|
232
BOK Financial
BOKF
$7.01B
| $1.52M | 0.11% |
15,526
+1,009
| +7% | +$98.5K |
|
233
Cisco
CSCO
$268B
| $1.52M | 0.11% |
21,833
+15,297
| +234% | +$1.06M |
|
234
PTC Therapeutics
PTCT
$4.66B
| $1.51M | 0.11% |
+30,982
| New | +$1.51M |
|
235
HUB Group
HUBG
$2.18B
| $1.51M | 0.11% |
45,010
+32,350
| +256% | +$1.08M |
|
236
Primerica
PRI
$8.7B
| $1.51M | 0.11% |
5,498
+10
| +0.2% | +$2.74K |
|
237
Red Rock Resorts
RRR
$3.62B
| $1.5M | 0.11% |
28,876
-3,570
| -11% | -$186K |
|
238
Hyster-Yale Materials Handling
HY
$637M
| $1.5M | 0.11% |
37,726
+17,941
| +91% | +$714K |
|
|
GTM
239
ZoomInfo Technologies
GTM
$3.55B
| $1.5M | 0.1% |
148,027
-11,350
| -7% | -$115K |
|
240
Encore Capital Group
ECPG
$991M
| $1.5M | 0.1% |
38,612
+6,034
| +19% | +$234K |
|
241
GE Vernova
GEV
$174B
| $1.49M | 0.1% |
2,811
-680
| -19% | -$360K |
|
242
Chubb
CB
$110B
| $1.49M | 0.1% |
+5,130
| New | +$1.49M |
|
243
Astronics
ATRO
$1.58B
| $1.48M | 0.1% |
44,264
+16,718
| +61% | +$560K |
|
|
MOMO
244
Hello Group
MOMO
$1.23B
| $1.47M | 0.1% |
+174,136
| New | +$1.47M |
|
245
Levi Strauss
LEVI
$8.55B
| $1.46M | 0.1% |
+79,195
| New | +$1.46M |
|
246
Howard Hughes
HHH
$4.66B
| $1.46M | 0.1% |
21,669
+3,297
| +18% | +$223K |
|
|
AMED
247
DELISTED
Amedisys
AMED
| $1.46M | 0.1% |
14,836
+11,484
| +343% | +$1.13M |
|
248
Ooma
OOMA
$350M
| $1.46M | 0.1% |
112,809
+78,539
| +229% | +$1.01M |
|
249
Dole
DOLE
$1.29B
| $1.44M | 0.1% |
102,669
+43,931
| +75% | +$614K |
|
250
CytomX Therapeutics
CTMX
$346M
| $1.43M | 0.1% |
630,809
-132,121
| -17% | -$300K |
|